ACTIV3b is testament that aviptadil works. unless the xrays
ACTIV3b is testament that aviptadil works. unless the xrays we were shown last year were fabricated, aviptadil works. aviptadil, like leronlimab, has been sidelined on technicalities and they are both extreme threats to the establishment.
the senate hearing is testament that fauci could give a rats ass. fauci may be getting royalties. no one is exactly sure the backdoor compensation he has been getting all along and we may never know. corruption to the extreme.
the fact that NIH can get royalties is testament that the system is as corrupt as it can possibly be and big pharma is the only player in the game allowed to score.
CYDY at .36 is testament that an effective drug with no side effects can be routinely ignored by authorities that have a different agenda than actually saving lives and curbing the damages of the pandemic.
even if this could all be proven in a court of law, it wouldnt matter. the courts may actually reward us in the amarex fraud/sabotage, but im not holding my breath.
how do we get past all of this? yes the pestell settlement is the right move to wade thru the muck and open certain doors. blowout data is our only friend and i do believe that is coming, but CD10/12 was considered a relative slam dunk and outside forces made sure it wasnt. just like fauci saying the DSMB, not fauci, has total leeway to look at the aviptadil data early (as an out for NOT looking at it, he sees ZERO urgency), the DSMB chose not to declare OUR mid trial data as positive either. and we found that some DSMB members were gilead connected.
are we living in china/russia/north korea? when will blatant conflict of interest ever be rectified? its literally killing people
6
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...
Continue Reading
Facing the Class Action Deadline There's nothing like a looming deadline to stir the pot, and that's exactly what's happening with D-Wave Quantum Inc. (NASDAQ: QBTS) as it faces the heat of a class action lawsuit. Investors who got caught in the slide between February 26, 2026, and August 25, 2026, need to sharpen their pencils and mark December 15, 2026, on their...
Continue Reading
Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...
Continue Reading
LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...
Continue Reading
Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...
Continue Reading
Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...
Continue Reading
Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...
Continue Reading
Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...
Continue Reading
The Ripple Effect of Tragedy Grief has a way of shaking a community down to its core—especially when the loss emanates from such senseless violence as the shooting death of 17-year-old Levi Brown. This wasn't just a tragic occurrence at a Friday night football game in Bakersfield; it was a visceral crack in the perceived safety of community events. Levi's Legacy and...
Continue Reading
Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...
Continue Reading
Top 5 Most Recently Viewed Articles
Rockwell Automation Enhances Lucid's EV Manufacturing Rockwell Automation, Inc. (NYSE: ROK), renowned for its commitment to industrial automation and digital transformation, is set to significantly enhance the electric vehicle (EV) production capabilities for Lucid. This collaboration aligns with Saudi Arabia's Vision 2030, aiming to develop a sustainable and diversified...
Continue Reading
TeraWulf Stock Overview TeraWulf Inc. (NASDAQ: WULF) is observing fluctuations in its stock value amidst significant financial developments. The company's stock experienced a minor drop of 0.96%, settling at $9.29 in pre-market trading. Investors are closely monitoring the implications of recent announcements on the company's future Convertible Notes Offering Details...
Continue Reading
Kaltura got analysts buzzing back in 2024 with their second-quarter results that had the desks reeling. Adjusted EBITDA hit $1.6 million when everyone was just hoping for $0.2 million. Revenue? $44 million, up from the expected $43.1 million—these numbers showed Kaltura wasn’t just treading water; they were swimming against the tide. Kaltura's Performance Metrics: A...
Continue Reading
Nvidia's Rise as a Technological Powerhouse Nvidia Corporation (NASDAQ: NVDA) has reached a new peak in its market valuation, crossing a staggering $4 trillion. Investors have welcomed the recent news regarding the resumption of sales of its advanced AI chips, boosting trust in the company's future prospects. This surge heightens interest in Nvidia, showcasing a potential...
Continue Reading
Oil Prices Facing Declines Recent trends indicate that oil prices have been on a downward trajectory, particularly influenced by uncertainties surrounding geopolitical tensions and tariffs imposed by the U.S. However, a critical observation is that these factors intertwine to significantly affect global economic conditions and energy demand. Current Status of Oil Pricing...
Continue Reading